Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
By interweaving nucleic acid scientists with clinicians dedicated to finding new cures, our goal is to create a new paradigm for organizing molecular research that enables the rapid application of new biological discoveries to solutions for unmet challenges in human health. Our current focus is on Huntington’s disease, alpha-1 antitrypsin deficiency, viral infections, preeclampsia, cancer, and more.
Listen to Phillip Zamore discuss Gene Silencing through RNAi with 'Finding a Genius' Podcaster Richard Jacobs.
Congratulations, Phillip D. Zamore, NIH MIRA awardee for Understanding the Evolution, Biology, and Molecular Mechanism of Argonaute Proteins!
Congratulations, Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars for their COVID-19 research!
Congratulations, Erik Sontheimer, Ph.D., Professor and Vice Chair, on his appointment to the Pillar Chair in Biomedical Research!
Congratulations, Anastasia Khvorova, recipient of the Women in Science & Health Achievement Faculty Award!
RNA therapeutics on the rise. New analysis from the Watts lab.
More RTI news...
For decades, scientists at the University of Massachusetts Medical School have been pioneers in RNA biology and leading innovators in the development of information-based therapeutics: cutting-edge therapeutic tools that leverage our advanced understanding of the human genome in ways that are revolutionizing how we treat disease. With your support, we are poised to unleash their power, and change the world for the better.
